The new contract marks the eighth health plan for Dario
and will contribute to revenues starting immediately.
NEW
YORK, Oct. 30, 2024 /PRNewswire/ -- DarioHealth
Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the
global digital health market, announced today a new contract with a
regional health plan in the Medicaid space, which has launched with
the full suite of cardiometabolic solutions.
The launch with this new health plan marks the third Medicaid
client for Dario, continuing a solid momentum within the Medicaid
space. The newly signed health plan, familiar with Dario's results
with another regional health plan, chose Dario based on the
Company's success and reputation for driving engagement among
diverse populations. Dario's ability to drive highly personalized
member experiences across a wide range of channels and support
modalities is attractive to Medicaid plans managing members with
limited access to traditional channels. Starting with an initial
pilot program, Dario will work closely with the health plan to
bring its proven solutions to the plan's population, which includes
nearly 10,000 Medicaid members.
"We believe that this contract demonstrates our ability to drive
user engagement with historically hard-to-reach Medicaid
populations, a challenge that few in our industry have successfully
addressed," said Steven Nelson,
Chief Commercial Officer at Dario. "Medicaid members present unique
engagement challenges for digital health solutions, but our track
record and novel approach to engagement has proven that Dario is
ideally suited for this population. We pride ourselves on
delivering value to our clients, which in this case has paved the
way to this new relationship, which we estimate will contribute to
our revenues in the fourth quarter of 2024. We see much more
opportunity to expand in this segment of the market and we are
committed to broadening our strategy to further our focus on
Medicaid in 2025."
About DarioHealth Corp.
DarioHealth Corp. (Nasdaq: DRIO) is a leading digital health
company revolutionizing how people with chronic conditions manage
their health through a user-centric, multi-chronic condition
digital therapeutics platform. Dario's platform and suite of
solutions deliver personalized and dynamic interventions driven by
data analytics and one-on-one coaching for diabetes, hypertension,
weight management, musculoskeletal pain and behavioral
health.
Dario's user-centric platform offers people continuous and
customized care for their health, disrupting the traditional
episodic approach to healthcare. This approach empowers people to
holistically adapt their lifestyles for sustainable behavior
change, driving exceptional user satisfaction, retention and
results and making the right thing to do the easy thing to do.
Dario provides its highly user-rated solutions globally to
health plans and other payers, self-insured employers, providers of
care and consumers. To learn more about Dario and its digital
health solutions, or for more information, visit
http://dariohealth.com.
Cautionary Note Regarding Forward-Looking Statements
This news release and the statements of representatives and
partners of DarioHealth Corp. related thereto contain or may
contain forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995. Statements that
are not statements of historical fact may be deemed to be
forward-looking statements. For example, the Company is using
forward-looking statements in this press release when it
discusses the benefits of the Company's solutions,
particularly with respect to Medicaid members; the Company's
ability to drive user engagement with historically hard-to-reach
Medicaid populations; the expectation that the new
relationship will contribute to its revenues in the fourth quarter
of 2024; the Company's future opportunities to expand in the
Medicaid segment of the market; and the company's commitment to
broadening its strategy and further its focus on Medicaid in
2025. Without limiting the generality of the foregoing, words
such as "plan," "project," "potential," "seek," "may," "will,"
"expect," "believe," "anticipate," "intend," "could," "estimate" or
"continue" are intended to identify forward-looking statements.
Readers are cautioned that certain important factors may affect the
Company's actual results and could cause such results to differ
materially from any forward-looking statements that may be made in
this news release. Factors that may affect the Company's results
include, but are not limited to, regulatory approvals, product
demand, market acceptance, impact of competitive products and
prices, product development, commercialization or technological
difficulties, the success or failure of negotiations and trade,
legal, social and economic risks, and the risks associated with the
adequacy of existing cash resources. Additional factors that could
cause or contribute to differences between the Company's actual
results and forward-looking statements include, but are not limited
to, those risks discussed in the Company's filings with the U.S.
Securities and Exchange Commission. Readers are cautioned that
actual results (including, without limitation, the timing for and
results of the Company's commercial and regulatory plans for Dario™
as described herein) may differ significantly from those set forth
in the forward-looking statements. The Company undertakes no
obligation to publicly update any forward-looking statements,
whether as a result of new information, future events or otherwise,
except as required by applicable law.
DarioHealth Corporate Contact
Mary Mooney
VP Marketing
mary@dariohealth.com
+1-312-593-4280
DarioHealth Investor Relations Contact
Kat
Parrella
Investor Relations Manager
kat@dariohealth.com
+315-378-6922
Media Contact
Scott
Stachowiak
Scott.Stachowiak@russopartnersllc.com
Logo:
https://mma.prnewswire.com/media/1920436/DarioHealth_Logo.jpg
View original
content:https://www.prnewswire.com/news-releases/dario-signs-new-regional-health-plan-expanding-reach-in-medicaid-population-302291351.html
SOURCE DarioHealth Corp.
